Speaker Q & A
If you missed the Q&A during the virtual presentation, ask your question below for the speakers. Click the “Reply” button in the presentation thread you’re interested in to post your question.
 |
 |
 |
 |
 |
If you missed the Q&A during the virtual presentation, ask your question below for the speakers. Click the “Reply” button in the presentation thread you’re interested in to post your question.
From Farm to Pharmacy: A Strawberry-Derived Solution to Oral Protein Delivery
Kathryn A. Whitehead, Ph.D.
Associate Professor Carnegie Mellon University
Building Novel Immune Cell Agonist Anti-Cancer Agents out of Bicycle Parts
Kevin McDonnell
Bicycle Therapeutics
Toward Universal Druggability
Gregory Verdine
Harvard University and Harvard Medical School
Fog Pharmaceuticals and LifeMine Therapeutics
Adrenomedullin Functions at the Maternal-Fetal Interface
Kathleen Caron
University of North Carolina at Chapel Hill
Empowering Peptide Science through Easy 18F-labelling for PET Imaging and New Stapling Methods Inspired by Natural Product Toxins
David M. Perrin
University of British Columbia
A Peptide Engineering Platform for PEG-FA Stapled Long-acting Peptide Hormones
Weijun Shen
Calibr at Scripps Research
Novel Therapeutics for Inflammatory Disorders of Pregnancy-Opportunities and Challenges
Sarah Robertson
The University of Adelaide
Deadly Cures: A Spider-Venom Peptide for Treating Ischemic Injuries of the Heart and Brain
Glenn King
The University of Queensland
Peptides for Molecular Recognition and Brain Delivery
Ernest Giralt
Institute for Research in Biomedicine (IRB Barcelona)
Novel Pairings in the Human Peptide-Receptor Signaling System
David E. Gloriam
University of Copenhagen
Chimeric Macrocyclic Peptide Antibiotics Against WHO Priority 1 Gram-Negative Bacteria Targeting both Lipopolysaccharide and BamA
Daniel Obrecht
Polyphor AG
Cyclic Cell-Penetrating Peptides: Mechanism of Action and Applications
Dehua Pei
The Ohio State University
GI Device Development in a Few Movements
Giovanni Traverso
Massachusetts Institute of Technology, Brigham and Women’s Hospital
GEN-009: A Neoantigen Vaccine Based on Autologous Peptide Immune Responses
GEN-011: Transforming T cell Therapy for Solid Tumors
Daniel DeOliveira
Genocea Biosciences, Inc.
Vasopressin: Old Dog. New Tricks
Michael Brownstein
Azevan Pharmaceuticals
Dual Myristic Acid (Myr) and Trans Activator of Transcription (Tat) Conjugated Peptides: A Potential Platform Technology for Intracellular Cargo Delivery
Lindon Young
Philadelphia College of Osteopathic Medicine
Kerry-Anne A. Perkins
Virtua Memorial Hospital